[Treatment of urogenital cancers with oral VP-16].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D005047:Etoposide / Q000378:metabolism / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D014565:Urogenital Neoplasms / Q000188:drug therapy* / Q000378:metabolism
D005047:Etoposide